PMC:7381711 / 7058-7315 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T55","span":{"begin":100,"end":106},"obj":"Body_part"},{"id":"T56","span":{"begin":151,"end":158},"obj":"Body_part"}],"attributes":[{"id":"A55","pred":"fma_id","subj":"T55","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A56","pred":"fma_id","subj":"T56","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T7","span":{"begin":100,"end":106},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-PubTator","denotations":[{"id":"249","span":{"begin":69,"end":83},"obj":"Gene"},{"id":"250","span":{"begin":100,"end":131},"obj":"Gene"},{"id":"251","span":{"begin":90,"end":93},"obj":"Gene"},{"id":"262","span":{"begin":41,"end":53},"obj":"Disease"},{"id":"263","span":{"begin":57,"end":63},"obj":"Disease"},{"id":"264","span":{"begin":193,"end":202},"obj":"Disease"},{"id":"265","span":{"begin":244,"end":256},"obj":"Disease"}],"attributes":[{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"Gene:7056"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"Gene:7035"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"Gene:462"},{"id":"A262","pred":"tao:has_database_id","subj":"262","obj":"MESH:D001778"},{"id":"A263","pred":"tao:has_database_id","subj":"263","obj":"MESH:D018805"},{"id":"A264","pred":"tao:has_database_id","subj":"264","obj":"MESH:D003643"},{"id":"A265","pred":"tao:has_database_id","subj":"265","obj":"MESH:D001778"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T69","span":{"begin":41,"end":53},"obj":"Disease"},{"id":"T70","span":{"begin":244,"end":256},"obj":"Disease"}],"attributes":[{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0001531"},{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0001531"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":141,"end":150},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T91","span":{"begin":114,"end":131},"obj":"Chemical"},{"id":"T92","span":{"begin":122,"end":131},"obj":"Chemical"},{"id":"T93","span":{"begin":151,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_76932"},{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A93","pred":"chebi_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-sentences","denotations":[{"id":"T46","span":{"begin":0,"end":257},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T18","span":{"begin":41,"end":53},"obj":"Phenotype"},{"id":"T19","span":{"begin":57,"end":63},"obj":"Phenotype"},{"id":"T20","span":{"begin":244,"end":256},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0003256"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0100806"},{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}

{"project":"2_test","denotations":[{"id":"32519894-31104069-2138167","span":{"begin":85,"end":87},"obj":"31104069"},{"id":"32519894-11597289-2138168","span":{"begin":95,"end":97},"obj":"11597289"},{"id":"32519894-12851279-2138169","span":{"begin":133,"end":134},"obj":"12851279"},{"id":"32519894-22616830-2138170","span":{"begin":162,"end":164},"obj":"22616830"}],"text":"However, studies that have targeted this coagulopathy in sepsis with thrombomodulin (40), AT3 (42), tissue factor pathway inhibitor (1), and activated protein C (31) have all failed to improve mortality, despite improving laboratory indexes of coagulopathy."}